FDA Approves First Therapy for Rare Pediatric Immune Disorder
The US Food and Drug Administration has approved the regenerative tissue-based therapy Rethymic for patients with congenital athymia, a rare
Read more
The US Food and Drug Administration has approved the regenerative tissue-based therapy Rethymic for patients with congenital athymia, a rare
Read moreA research group including Professor Matsuda Tetsuya of Tamagawa University’s Brain Science Institute and Assistant Professor Ishihara Toru from Kobe
Read moreTaking teens’ strengths, values, and dreams, into account through a previsit questionnaire was acceptable to them and may promote discussions
Read more(Reuters Health) – Using an electronic tablet to deliver a six-item screening tool to minors in a pediatric emergency department
Read moreCancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center
Read moreSeizure disorders in babies are frightening and heartbreaking. A new basic science breakthrough offers hope for a potential treatment for
Read morePeople with borderline personality disorder are 13 times more likely to report childhood trauma than people without any mental health
Read moreResearchers from the Universities of Cardiff and Bristol have devised a test that could in future help to identify children
Read moreNeuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%. For the
Read moreAdults with lupus who report having had adverse childhood experiences (ACEs), such as abuse, neglect and household challenges, report higher
Read more